Table 3. Sociodemographic and clinical aspects according to occurrence of cognitive disorder.
| No cognitive impairment (n=133) | Impairment in multiple cognitive domains (n=238) | p-value | ||
|---|---|---|---|---|
| Age (years) | 44.1 (±15.0) | 51.1 (±16.9) | <0.001* a | |
| Educational level (years) | 6.8 (±3.6) | 5.0 (±3.7) | <0.001* a | |
| Age at onset (years) | 23.2 (±15.9) | 28.9 (±22.6) | 0.005* a | |
| Duration of epilepsy (years) | 20.9 (±15.3) | 22.2 (±17.1) | 0.459a | |
| Sex | Female | 76 (41.9%) | 105 (58%) | 0.016* b |
| Male | 57 (30%) | 133 (70%) | ||
| Antiepileptic drugs | 1 | 94 (70.6%) | 39 (29.3%) | 0.042* b |
| ≥2 | 143 (60%) | 95 (39.9%) | ||
| Epileptic syndrome | Genetic | 12 (54.5%) | 10 (45.4%) | 0.002* c |
| Focal unknown etiology | 55 (45.4%) | 66 (55.4%) | ||
| Focal structural | 66 (28.9%) | 162 (71%) | ||
| Epilepsy | TLE-HS (113) | 39 (34.5%) | 74 (65.4%) | 0.037* c |
| Unknown etiology and genetic | 68 (47.5%) | 75 (52.4%) | ||
| TLE-HS laterality | Right (n=50) | 20 (40%) | 30 (60%) | 0.261b |
| Left (n=56) | 18 (32.1%) | 38 (67.8%) | ||
TLE-HS: Temporal lobe epilepsy with hippocampal sclerosis;
a
t-test;
b
Fisher's exact test;
c
Chi-square test;
*
p<0.05.